Clinical Trials

ClinicalTrials.gov registrations across deep tech.

Showing 24 of 19,428 clinical trials

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

NCT07720388Started about 1 month ago

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: University of Colorado Denver

Source: ClinicalTrials.gov · Synced 4 days ago

Interprofessional Simulation Program for Clinical Resilience and Empathy (INSPIRE) for Healthcare Teams Caring for Birthing Individuals With Substance Use Disorder in Utah

NCT07707115Started about 1 month ago

NARECRUITINGINTERVENTIONAL

Sponsor: University of Utah

Source: ClinicalTrials.gov · Synced 4 days ago

Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)

NCT07582016Started about 1 month ago

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: University of Utah

Source: ClinicalTrials.gov · Synced 4 days ago

Comparing Two Moral Injury Treatments: Acceptance and Commitment Therapy for Moral Injury and Present Centered Therapy for Moral Injury

NCT07710521Started about 1 month ago

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: VA Eastern Colorado Health Care System

Source: ClinicalTrials.gov · Synced about 2 months ago

Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults

NCT07539987Started about 1 month ago

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

NCT07648953Started about 1 month ago

NARECRUITINGINTERVENTIONAL

Sponsor: University of Utah

Source: ClinicalTrials.gov · Synced 4 days ago

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

NCT06458907Started about 1 month ago

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: P+F Products + Features USA Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 1b Study of Safety, Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)

NCT07521046Started about 1 month ago

PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Feasibility and Usability of a Chest-Strap Ambulatory ECG Monitor in Active Individuals in Comparison With a Traditional Ambulatory ECG Patch Monitor (MoMe ARC)

NCT07772817Started about 1 month ago

RECRUITINGOBSERVATIONAL

Sponsor: Mayo Clinic

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 2, Multicenter, Randomized, Double-Blind, 52-week Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT07759245Started about 1 month ago

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: ELI LILLY AND COMPANY

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

NCT07697456Started about 1 month ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: AbbVie

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 4, Open-Label Trial to Evaluate the Safety and Effectiveness of Sebetralstat When Used as Preprocedural Short-term Prophylaxis in Patients With Hereditary Angioedema

NCT07654829Started about 1 month ago

PHASE4NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: KalVista Pharmaceuticals, Ltd.

Source: ClinicalTrials.gov · Synced about 2 months ago

Transcranial Direct Current Stimulation to Treat Aphasia: A Superiority Study

NCT07688551Started about 1 month ago

PHASE2PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 2, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Treatment Following Induction With Efgartigimod Administration in Adults With Myasthenia Gravis

NCT07673744Started about 1 month ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: TG Therapeutics, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Randomized Placebo-procedure Controlled Trial of the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System PULmonary Artery Denervation Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT07214376Started about 1 month ago

NARECRUITINGINTERVENTIONAL

Sponsor: Pulnovo Medical, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults

NCT07616128Started about 1 month ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Evommune, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 3, Randomized, Double-Blind Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Participants With Obesity or Overweight With Type 2 Diabetes Mellitus

NCT07684144Started about 1 month ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Amgen

Source: ClinicalTrials.gov · Synced 4 days ago

A Prospective, Multi-National, Randomized, Double-Blind, Crossover Study to Evaluate the Efficacy and Safety of Gadopiclenol-enhanced MRA Compared to Gadoterate Meglumine-enhanced MRA in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

NCT07348640Started about 1 month ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Guerbet

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, With and Without an Anti-EGFR Antibody, and With an Anti-EGFR Antibody and Chemotherapy, in Patients With Metastatic KRAS G12D-Mutated Colorectal Adenocarcinoma (TARGET-D 203)

NCT07659795Started about 1 month ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Verastem, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

CSP #2041 - Cessation or Reduction of Alcohol Consumption in VEterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE)

NCT07218354Started about 1 month ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: VA Office of Research and Development

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion

NCT07492680Started about 1 month ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Bristol-Myers Squibb

Source: ClinicalTrials.gov · Synced 4 days ago

A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)

NCT07497087Started about 1 month ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Boehringer Ingelheim

Source: ClinicalTrials.gov · Synced 4 days ago

A Modular, Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Efficacy of AZD4045, an Allogeneic Chimeric Antigen Receptor-T Cell (CAR-T) Therapy Targeting B Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

NCT07681596Started about 1 month ago

PHASE1PHASE2RECRUITINGINTERVENTIONAL

Sponsor: AstraZeneca

Source: ClinicalTrials.gov · Synced 4 days ago

ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)

NCT07568015Started about 1 month ago

NARECRUITINGINTERVENTIONAL

Sponsor: Brixton Biosciences, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

Load more (24)

Trial data sourced from ClinicalTrials.gov, a service of the U.S. National Library of Medicine.